BioTech/Drugs - Edmonton, AB, CA
Metabolomic Technologies Inc. (MTI) is engaged in using the new science of metabolomics to deliver innovative non-invasive diagnostics to the healthcare market. MTI's flagship product, PolypDx™, is the first and only urine-based test with a high sensitivity for detecting adenomatous polyps, the precursor to colorectal cancer, thus providing doctors with a new tool for early screening and detection.
reCAPTCHA
Gmail
Google Maps
DigitalOcean
YouTube